Mary Ann Hodorowicz, RD, LDN, MBA, CDE, CEC
Mary Ann Hodorowicz is an RD and CDE and earned her MBA with a focus on marketing. She is also a Certified Endocrinology Coder and owns a private practice specializing in business clients in Palos Heights, Illinois.
She is a consultant, professional speaker, trainer and author for the health, food and pharmaceutical industries in nutrition, wellness, diabetes and Medicare and private insurance reimbursement.
Her clients include healthcare entities, professional membership associations, pharmacies, medical CEU education/training firms, government agencies, food and pharmaceutical companies, academia and employer groups.
She is on the faculty of several train-the-trainer programs, including the Johnson and Johnson Diabetes Institute, Pesi Healthcare, and a pharmacy program for training on DSMT accreditation by AADE, Present Diabetes e-Learning Systems, Balancing Life's Issues, and is on the speaker's bureau of Novartis/Nestle Nutrition, Inc..
Mary Ann has given over 300 professional presentations and webinars for several healthcare organizations and business entities. She has authored several resources, articles and tool kits for the Academy of Nutrition and Dietetics and AADE, has served on the editorial advisory board for AADE in Practice, and has continually served on president-elect committees of the Academy. Mary Ann is on the Board of Directors for AADE.
In her career, she has provided outpatient MNT and DSME, designed a hospital Outpatient Diabetes Center and recognized DSME program and worked as a Clinical Nutrition Manager, Assistant Director of a hospital Food and Nutrition Services Department and an ADA Dietetic Traineeship Director.
Brie and Mango Quesadillas Hot Hot Hot Chicken Tostadas and Beans Brie Covered with Parmesan and Breadcrumbs Hot Pepper and Lemon Sauce Antipasti Red Potato Salad (Gluten Free) Broccoli, Tomato, and Chickpea Salad Cool Shrimp Dip Grilled Squash Cranberry Orange Muffins
Most of the time, we bash the lastest news about a "diabetes cure" because it is neither a cure, nor often even a significant improvement in diabetes treatment. Usually these "cures" are tested in mice, but fail to make the leap over to human physiology. Devices may work in the lab, but take decades to pass through FDA review, and still not be much better than what we already have. It's enough to make us all jaded. I know I am. But I saw something...